Relevant concomitant care permitted or prohibited during the trial {11d}
During the trial, NHSBT standard care has been in place to ensure donor safety. This includes a screening procedure to ensure the donor is healthy and any medication does not impact donor health or the donation process (including study interventions). As noted above, if a donor has declined to receive the trial intervention, they have been offered standard care.